P soriasis, a common autoimmune disease with a prevalence of 2-3% in the worldwide population depicting with characteristic erythematous skin lesions covered with white silvery scales, is associated with severely reduced quality of life (1) . Ten to 40% of psoriasis patients develop a destructive arthritis.
Abnormal function of T lymphocytes is considered a major cause of psoriasis (2-4). Dysfunctional regulatory T cells (Tregs) contribute to the unrestrained generation of pathogenic T cells in psoriasis in humans and in the CD18
hypo PL/J mouse model as reported earlier (5-7). CD4 +
CD25
high+ Foxp3 + naturally occurring Tregs (nTregs) expressing transcription factor (TF) Foxp3, a master regulator of Treg development and function (8) , are normally considered inhibitors of autoimmune responses (recently reviewed in Ref. 9 ). Under proinflammatory conditions, however, Tregs may differentiate into inflammation-associated Th17 cells, a paradigm shift with as yet largely unknown consequences for human disease initiation or progression (8, 9) . Deficiency in CD4 + CD25 high
Foxp3
+ Tregs mainly plays a role in acute exacerbation of psoriasis when the balance of immune suppression and immune activation is just about to shift, whereas disease maintenance occurs through amplification of inflammatory cytokines (7) . Th17 cells, a subset of Th cells characterized by production of IL-17 and expression of TF retinoic acid-related orphan receptor (ROR) a and g (10, 11) , have been implicated in the pathogenesis of psoriasis and other autoimmune inflammatory diseases (12, 13) . Although the primary function of Th17 cells is the clearance of pathogens that are not adequately handled by Th1 or Th2 cells, Th17 cells are also potent inducers of tissue inflammation due to production of effector cytokines such as IL-17, IL-21, and IL-22. Earlier work established IL-23 as a survival factor for Th17 cells and showed that in vitro differentiation of Th17 cells unexpectedly proceeds through a developmental pathway partially shared with the anti-inflammatory Foxp3 + Treg population (reviewed in Ref. 14) .
We previously reported on the CD18 hypomorphic (CD18 hypo ) PL/J mouse model of psoriasis with reduced expression of CD18 (b 2 integrin, Itgb2) to 2-16% of wild-type levels as a consequence of a hypomorphic gene mutation (15) (16) (17) (18) . CD18 represents the common b-chain of four different heterodimeric integrins expressed on distinct hematopoietic cell subsets, namely CD18/ CD11a, CD18/CD11b, CD18/CD11c, and CD18/CD11d, that as leukocyte adhesion molecules regulate cell-cell contacts through interaction with .20 known ligands, such as ligands of the ICAM family (19, 20) . Homozygous CD18 hypo PL/J mice spontaneously develop a T cell-mediated psoriasiform skin disease at 12-14 wk of age that closely resembles human psoriasis histologically, clinically, and in its polygenic base (16, 21) . Evidence indicating that reduced CD18 expression may also causally be involved in the development of psoriasis in humans comes from the clinical observation that some patients suffering from leukocyte adhesion deficiency syndrome 1, even with moderately reduced CD18 expression levels, develop a psoriasiform skin disease (22) . Linkage analysis of psoriasis families has identified a susceptibility locus within a region on chromosome 17, which includes the ICAM-2 locus, an important ligand of the CD11/CD18 heterodimers (23) .
According to recent studies, peripheral blood-derived Tregs from patients with severe psoriasis easily differentiate into a Th17-associated phenotype, a process promoted by IL-23 (24, 25) . Previous data from our group (6) hypo PL/J Tregs into Th17 cells in vitro and in vivo in greater detail. We found that altered nTreg development in thymi of young, still unaffected CD18 hypo PL/J mice and peripheral conversion of Tregs into Th17 cell both contribute to the loss of tolerance in CD18 hypo PL/J mice, ultimately resulting in the clinical manifestation of psoriasiform dermatitis. These findings further support the concept that CD18 heterodimeric molecules, through their role in mediating cell-cell contacts between immune cell subsets, are essential for proper development and function of nTregs, peripheral Treg maintenance, and the suppression of psoriasiform skin disease in PL/J mice.
Materials and Methods
Mice PL/J mice with a hypomorphic mutation of the CD18 gene (CD18 hypo ) have been described (8) . CD18 +/+ littermates (CD18 wt ) resulting from heterozygous crosses served as wild-type controls. To evaluate the severity of the psoriasiform phenotype, an adapted psoriasis area and severity index score was determined for affected CD18 hypo PL/J mice used for experiments as described earlier (16) . The modified psoriasis area and severity index score reflects the following clinical phenotypes: 0, no symptoms; 1, slight erythema of the ears; 2, strong erythema of the ears; 3, slight hair loss on the head; 4, extensive hair loss, including the trunk; 5, slight hair loss, isolated scaling; 6, extensive hair loss, isolated scaling; 7, extensive hair loss, widespread slight scaling; 8, moderate scaling of a large area of the body; 9, widespread hair loss, strong scaling of a few smaller areas; and 10, extensive hair loss, extensive scaling of a large area of the body. For all experiments, CD18 hypo PL/J mice displaying a strong psoriasiform phenotype were used. All mice were kept in the animal facility of the Tierforschungszentrum of the University of Ulm under pathogen-free conditions. All procedures were done in accordance with the guidelines for animal experimentation approved by the Regierungspräsidium Tübingen, Germany.
FACS analysis
Abs used for FACS analysis are as follows: PerCP-conjugated rat anti-mouse CD4 (clone RM4-5; BD Biosciences), PE-Cy7-conjugated anti-CD4 (clone-GK1.5; eBioscience), PE-conjugated rat anti-mouse CD25 (Miltenyi Biotec), eFluor 450-conjugated anti-mouse CD127 (clone-A7R34; eBioscience), Alexa Fluor 647-conjugated anti-Foxp3 (clone-MF23; BD Biosciences), FITC-conjugated anti-mouse IL-17A (clone eBio17B7; eBioscience), allophycocyanin-Cy7-conjugated IL-17A (clone-TC-11-18H10; BD Biosciences), Alexa Fluor 488-conjugated anti-Stat5 pY694 (BD Biosciences), and PerCP-conjugated ROR g(t) (clone B2D; eBioscience). Cells isolated from spleens of CD18 wt PL/J and CD18 hypo PL/J mice were processed for FACS analysis as previously described (16) . To monitor Foxp3 and IL-17 expression on mouse Tregs, Tregs cocultured with allogeneic dendritic cells (DCs) were first stained for surface markers with anti-CD4, anti-CD25, and anti-CD127 Abs on days 0, 3, and 7. After fixation and permeabilization, intracellular Foxp3 followed by IL-17A was detected using the mouse Foxp3 buffer Set (BD Pharmingen) according to the manufacturer's protocols. Isotype IgG was used as control for all experiments. All FACS analyses were performed using an FACSCalibur and FACSDiva (BD Biosciences) as well as FlowJo (Tree Star) software.
Immunofluorescence staining
Frozen cryosections (5 mm) of mouse back skin and lymph nodes were fixed in ice-cold acetone for 10 min before staining. To detect T cell subpopulations, sections were first incubated with Ab against mouse CD4 (clone-L3T4; eBioscience) or Foxp3 (clone-FJK-16s; eBioscience). Alexa Fluor 488-conjugated anti-goat Ab (Molecular Probes) was used as a secondary Ab. Subsequently, anti-mouse IL-17 Ab (H-132; Santa Cruz Biotechnology) or anti-mouse RORgt (clone-Q31-378; BD Pharmingen) was added for the detection of IL-17-producing cells and RORgt as Th17-defining TF, respectively, followed by incubation with Alexa Fluor 555-conjugated secondary Abs (Molecular Probes). Isotype Ig served as negative control. DAPI (Sigma-Aldrich) was used to stain nuclei. All Abs were diluted in a 1% Ab diluent (DakoCytomation). Photomicrographs were produced using a Zeiss Axiophot microscope (Carl Zeiss) and corresponding software. + RORg + cells, positively stained cells were counted. For all measurements, the median of specifically stained cells counted in 15 high-power fields is presented (n $ 3). Scale bars, 100 mm; 300 mm in the corresponding enlarged microphotographs. **p , 0.05, ***p , 0.01. querade as Th17 cells (26), we subsequently also examined coexpression of RORgt, the key TF required for differentiation of Th17 cells, with Foxp3 in the skin infiltrate (27) (Fig. 2E, 2F ) or immigrated from skin-draining lymph nodes also harboring increased fractions of Foxp3 + RORgt + DP cells (Supplemental Fig. 1 ).
Treg and DC preparation
Reduced CD18 levels increase the propensity of CD18 wt PL/J mice using the methods described above and subsequently cocultured with allogeneic bone marrow-derived irradiated DCs from BALB/c mice in the presence of 500 U/ml recombinant murine IL-2. IL-2 is required for Treg maintenance and expansion, but is also capable of inducing Th17 conversion (28) . Foxp3 and IL-17A expression were analyzed on days 0, 3, and 7 by intracellular cytokine staining and subsequent FACS analysis. The purity of the Treg starting population used for the Treg/Th17 differentiation experiments was generally .93% on day 0 as confirmed by their CD4 + CD25 + CD127 2 Foxp3 + phenotype by FACS analysis (Fig.   3A, left panel) . By trend, CD18 hypo PL/J Tregs expressed slightly higher IL-17 levels on day 0, possibly resulting from an endogenous defect or from the inflammatory milieu in diseased mice. After the 7-d stimulation period, the resulting total CD4 + population of the CD18 hypo PL/J samples contained a higher total fraction of IL-17 + cells compared with CD18 wt PL/J samples (Fig.  3A, right panel) corresponding to a differentiation process of the original Foxp3 high+ Tregs already detectable to some extent on day 3 (Fig. 3A, middle panel) (Fig. 3B) . Among these two populations, both Foxp3 high and Foxp3 low cells expressed IL-17A (Fig. 3C) wt PL/J mice were cocultured with allogeneic bone marrow-derived irradiated DCs from BALB/c mice in the presence of 500 U/ml recombinant murine IL-2 as described above. No significant increase of IL-17-producing cells was observed, and the IL-17-positive T cell fraction was below 1-1.5% on day 7 independent from the CD18 status (Fig. 3D, 3E) wt PL/J mice as described above. Low basal IL-17 production could be detected in Tregs derived from BALB/c mice on day 0, but no major increase in IL-17 production occurred by day 7 independent from the CD18 levels on PL/J DCs (Supplemental Fig. 2 Fig. 3 ).
Blocking of CD18 with neutralizing anti-CD18 Ab induces conversion of CD18 wt Tregs into IL-17A-producing cells in Treg-DC cocultures in vitro
To confirm that the enhanced differentiation of CD18 hypo PL/J Tregs into Th17 cells observed in vitro is a consequence of reduced CD18 expression (i.e., CD18-dependent) and to analyze the dose-response effect of diminished CD18 levels on Treg plasticity, we used anti-CD18 blocking Abs in cocultures of allogeneic DCs and Tregs derived from CD18 wt PL/J mice and, for comparison, also from CD18 hypo PL/J mice. Increasing concentrations of CD18 blocking Abs (0, 5, 10, and 20 mg/ml) were added to Treg-DC cocultures in the presence of 500 U/ml recombinant murine IL-2. In a control experiment, isotype control Abs at identical concentrations were used instead of anti-CD18 Abs. Expression of IL-17 was analyzed on days 0, 3, and 7 via FACS as described above. Notably, a significant upregulation of IL-17 in CD18 wt PL/J Tregs was dose-dependently observed on day 7 upon addition of neutralizing anti-CD18 Abs (Fig. 4A ) with concomitant decrease of Foxp3 levels (Fig. 4B , representative experiments are shown). Isotype control IgG did not induce any significant conversion of CD18 wt PL/J Tregs into Foxp3 low IL-17 + T cells. Moreover, anti-CD18 Abs did not cause in any significant increase in Treg apoptosis, and apoptotic cell fractions were generally ,10% upon addition of all concentrations of anti-CD18 used in this study (0-20 mg/ml) (data not shown). These results confirm a direct influence of the reduced CD18 expression on differentiation of Tregs into Th17 cells in the CD18 hypo PL/J mouse model. In a follow-up experiment, splenic Tregs from three individual CD18 wt PL/J mice were differentiated into IL-17 + cells applying 20 mg/ml anti-CD18 in the presence of IL-2 to statistically assess the reproducibility of the conversion effect. Tregs from all three mice had converted into IL-17 + Foxp3 low cells to similar extents on day 7 following anti-CD18 exposure with statistically highly significant increases in IL-17 + fractions and corresponding decreases in Foxp3 + fractions by up to ∼80% (Fig. 4C, 4D ).
Adoptively transferred CFSE-labeled Tregs derived from CD18
hypo PL/J mice differentiate into IL-17A-producing Th17 cells in vivo
To track the differentiation of Tregs into IL-17A-producing Th17 cells in vivo, Tregs purified from spleens of CD18 wt PL/J or CD18 hypo PL/J mice were labeled with CFSE as described above. For the homologous transfer experiments, a total of 1 3 10 6 CFSE-labeled Tregs from CD18 wt and CD18 hypo PL/J mice were injected i.v. into CD18 wt PL/J and CD18 hypo PL/J recipients, respectively. On day 7, recipient mice were analyzed for IL-17 production in CFSE-labeled cells recovered from spleens. Consistent with our in vitro results, we observed an enhanced production of IL-17 in CD18
hypo Tregs injected into CD18 hypo PL/J mice in comparison with CD18
wt Tregs in CD18 wt PL/J mice (Fig.  5A) . Notably, cells with lower CFSE fluorescence intensity on day 7 produced higher levels of IL-17, indicating that proliferating cells had preferentially differentiated into IL-17-producing cells.
To investigate a potential influence of the inflammatory environment on the differentiation process of Tregs, in a follow-up experiment, CFSE-labeled Tregs derived from CD18 wt and 
CD18
hypo PL/J mice were injected reciprocally into either CD18 hypo PL/J or CD18 wt PL/J recipients, respectively. Increased percentages of IL-17-producing CFSE-labeled CD18 hypo Tregs were found in CD18 wt PL/J recipients on days 3, 7, and 14 posttransfer, confirming that Tregs derived from CD18 hypo PL/J mice display an enhanced intrinsic propensity to differentiate into IL-17-producing Th17 cells compared with CD18
wt Tregs (Fig.  5B) . On day 14 post-reciprocal transfer, the frequency of IL-17-producing CFSE-labeled CD18 wt as well as CD18 hypo Tregs had further increased compared with days 3 and 7, confirming that Treg conversion was maintained over time. The significantly greater increase in conversion rates of CD18 hypo Tregs by day 14 compared with CD18
wt Tregs verified that the differences in Foxp3 + IL-17 + converters between CD18 hypo and CD18 wt PL/J mice were not attenuated with time, but actually became even more profound, further supporting our concept of promotion of Treg/Th17 conversion by suboptimal CD18 levels. Interestingly, we did not observe any major influence of the proinflammatory environment on CD18 hypo PL/J Treg plasticity, but instead, Treg differentiation into Th17 cells seemed to be primarily dependent on CD18 expression levels in our model.
Discussion
Previous investigations using CD18 + T cells was associated with defects in immune homeostasis and the subsequent development of autoimmune diseases, in particular autoimmune colitis and ileitis (29) . We demonstrate in this study that reduced expression of CD18 to 2-16% of wild-type levels similarly impacts the development of nTregs and, most interestingly, facilitates differentiation of peripheral Treg into IL-17-producing Th17 cells. Using the CD18 hypo PL/J murine psoriasis model, we found a dose-dependent relationship between CD18 expression levels on Tregs and their propensity to convert into IL-17-producing cells. The dose effect of CD18 expression on differentiation of Tregs into IL-17-producing cells was further substantiated in MLR in vitro when Tregs derived from CD18 competent mice in the presence of neutralizing Abs against CD18 dose-dependently adopted a Th17 phenotype. To our knowledge, this is the first study showing an impact of CD18 levels on Treg/Th17 plasticity and a pathogenic consequence in the murine CD18 hypo PL/J model of psoriasis. CD4 + CD25 high+ Foxp3 + Tregs critically contribute to the maintenance of immune homeostasis and immunological self-tolerance through suppression of pathological and physiological immune response. Thymic-derived nTregs and iTregs work in collaboration to prevent autoimmune responses (30) . The role of Foxp3 as key regulator of development and function of nTregs is quite evident, but its role in the differentiation of iTregs is less clear. In the present investigation, we further explored the relationship between Foxp3 expression levels and Th17 differentiation of Tregs in the CD18 hypo PL/J mouse model and successfully established a role for CD18 in Treg plasticity. Our results thus provide additional insights into pathogenic mechanisms of psoriasiform skin disease in the CD18 hypo PL/J mouse model, which most likely will be relevant to understanding human psoriasis. In fact, reduced CD18 expression levels have been identified on leukocytes in psoriasis patients (31) (32) (33) , and in an independent study, the conversion of Tregs into Th17 cells was convincingly shown in psoriasis patients (24) . In contrast to these rather correlative data, we provide in this study direct evidence for a causal relationship between CD18 CFSE labeled Tregs of either mouse strain were injected into CD18 wt or CD18 hypo PL/J recipients, respectively. On day 7 after transfer or as indicated, recipient mice were analyzed for IL-17 production in CFSE labeled Tregs (n $ 3 per mouse line and per time point expression levels and the enhanced conversion of Tregs into Th17 cells enhancing the psoriasiform phenotype in CD18 hypo PL/J mice. Although a complete block of CD11a/CD18 (LFA-1), previously also used therapeutically by anti-psoriatic drugs such as the Ab efalizumab (34) , primarily affects migration of autoreactive lymphocytes into the skin and may lead to symptoms of immunodeficiency comparable to human leukocyte adhesion deficiency as a consequence of decreased T cell activation, suboptimal CD18 function, and impaired interaction with its ICAM ligands on DCs-that is, mimicked in the CD18 hypo PL/J mouse model and potentially also occurs in psoriasis patients as a consequence of altered ICAM and or CD18 expression (17, 35) results in the Treg dysfunction described in this study and in autoimmunity such as psoriasiform skin disease in mice. Notably, apart from sporadic cases of progressive multifocal leukoencephalopathy, severe relapses of pustular psoriasis were reported in patients treated with efazilumab (34), possibly indicating that under nonsaturating efazilumab conditions, activated Teffs rush into the skin, whereas Tregs may be still suppressed or may not have functionally recovered from efazilumab treatment yet. In fact, due to these side effects, efazilumab has been withdrawn from the market.
The healthy thymus is capable of producing functional nTregs, but may also give rise to autoreactive, potentially pathogenic T cells. Although DP thymocytes with a high affinity to self-ligands presented by thymic epithelial cells are normally deleted through negative selection, thymocytes with an intermediate affinity for self-Ags that receive sufficient stimulation by TGF-b and IL-2 may become nTregs (recently reviewed in Ref. 36 ). This selection process can be influenced by negative regulatory signals modifying the TCR signaling threshold in thymocytes (37) . Mature Tregs persist in the periphery and exert dominant control over autoreactive T cells. Treg deficiency in the periphery is sufficient to evoke chronic T cell-mediated autoimmunity and immune pathology (8) . Our findings that reduced expression of CD18 in the CD18
hypo PL/J mouse model results in reduced numbers of nTreg precursors and CD4 + Foxp3 + nTregs in thymi of young CD18 hypo PL/J prior to the manifestation of psoriasiform dermatitis confirm a role for CD18 in early Treg commitment, likely through regulation of cell-cell contacts between Treg precursors and thymic stromal cells, modification of TCR signals, or through paracrine regulation of the abundance of cytokine-like IL-2 or IL-7 signals at the immunological synapses between developing Tregs and thymic stromal cells. Because LFA-1 enhances the affinity/avidity of the TCR for its MHC class II-peptide ligand by stabilizing T cell-DC contacts (38) , a reduction of CD18 in the CD18
hypo PL/J model might shift the threshold of selection in DP thymocytes, with fewer CD4 + CD25 + Treg precursors being selected and subsequent impact on Foxp3 upregulation.
IL-2R signaling is essential for the development, homeostasis, and activation of nTregs (39, 40) . IL-2 maintains Foxp3 + nTregs and facilitates TGF-b-dependent differentiation of naive T cells to Foxp3 + iTregs. Binding of IL-2 to its receptor induces phosphorylation of the TF Stat5, and p-Stat5 (pY694/pY699) activates Foxp3 transcription at the Foxp3 promoter, subsequently resulting in elevated levels of Foxp3 protein in Tregs (8, 41, 42 + cells is reduced. The exact molecular basis of defective CD25a/IL-2Ra upregulation in CD18 hypo PL/J T cells still needs to be analyzed in more detail and might involve alterations in calcium flux, calcineurin, and NF-AT signaling due to the suboptimal TCR stimulation in the context with an avidity/affinity shift of the precursor population.
Ziegler and Buckner (43) hypo PL/J skin, suggesting that, at least in part, Treg conversion actually occurs in the skin itself. Alternatively, Treg conversion might take place in secondary lymphoid organs other than the skin, in particular in lymph nodes, and converting cells migrate into CD18
hypo PL/J skin at enhanced rates due to alterations in trafficking and expression of skin-homing molecules in this psoriasis mouse model. As a consequence of the CD18 hypo mutation, trafficking of immune cells into the skin could be impaired, but levels of other surface receptors and chemokines involved in skin homing such as CCR6 or cutaneous lymphocyte Ag and CCL20 were found at increased levels in CD18 hypo PL/J skin (M. Gatzka, unpublished observations). In addition to the increased intrinsic propensity of CD18 hypo Tregs to convert into Th17 cells confirmed in our in vitro experiments, altered migration and expression of chemokine receptors on Tregs in vivo therefore likely contribute to the skin inflammation developing in CD18 hypo PL/J mice (45) (46) (47) . In the presence of IL-6, inhibition of RORgt by Foxp3 is abrogated, leading to initiation of Th17 differentiation (41) . The pivotal role of IL-6 in determining the balance between Tregs and Th17 cells could also be confirmed by another group in a model of experimental autoimmune encephalomyelitis (48) . A comparable process might trigger the onset of psoriasiform skin disease in CD18 hypo PL/J mice by favoring Foxp3 + Treg conversion into Th17 cells, gradually leading to a preponderance of inflammatory signals. In fact, increased levels of proinflammatory cytokines such as IL-6 and IL-23 in peripheral lymphoid organs of CD18 hypo compared with CD18 wt PL/J mice create an inflammatory environment (Supplemental Fig. 1 and data hypo PL/J mice may impair TCR activation, eventually leading to reduced proliferation, activation, and suppressor function of Tregs (6); however, the exact molecular pathways are still unknown and need to be examined in greater detail. In a previous investigation assessing the suppressor function of CD18 hypo PL/J Tregs, we in particular also found a reduced ability to produce TGF-b1 (6), a cytokine known to influence the Treg/Th17 balance (49, 50) .
To identify potential peripheral mechanisms for the observed decline of Treg numbers in affected CD18
hypo PL/J mice, we then further analyzed the impact of reduced CD18 expression on differentiation of a defined population of peripheral Tregs (CD4 (Figs. 3, 4, Supplemental Fig. 4 ) and the in situ (Fig. 2 ) and in vivo data (Fig. 5) , overall convincingly showing that CD18
hypo Tregs have an increased tendency to convert into Th17/IL-17-producing cells.
In summary, several CD18-dependent mechanisms that may jointly cause loss of Treg numbers and predominance of IL-17-producing T cells in CD18 hypo PL/J mice, thereby contributing to psoriasiform skin disease have been identified so far: 1) decreased production of nTregs already in young mice prior to the manifestation of psoriasiform dermatitis; 2) further reduction of thymic output of nTregs with age; 3) impaired peripheral Treg function and reduced production of TGF-b1; and 4) conversion of Tregs into IL-17-producing Th17 cells in inflamed skin and peripheral lymphatic organs. The function of CD18 hypo PL/J DCs seemed to be normal in terms of their effect on Treg maintenance and induction of Treg proliferation. Impaired interaction of Treg and DCs results in improper Treg activation followed by differentiation of Tregs into Th17 cells and subsequent hyperactivation of Teffs (15, 16) . These activated pathogenic Teffs, in the absence of fully functional Tregs, trigger a cascade of inflammatory events, including recruitment and activation of macrophages, with resulting overproduction of the proinflammatory cytokine TNF-a, eventually leading to unrestrained amplification of inflammatory circuits and the manifestation of the psoriasiform skin disease (18) . In conclusion, our data strongly confirm the central role of CD18 in T cell development, T cell activation, and regulation of autoimmunity. Additional work will now be performed to confirm the role of CD18 in Treg plasticity in human psoriasis patients as well as to directly track Treg conversion into Th17 cells in the skin of affected CD18 hypo PL/J mice using in vivo imaging techniques.
